RNU4-2
Chr 12ADARRNA, U4 small nuclear 2
Also known as: NEDHAFA, RENU, RNU4-1B, RNU4B1, RNU4C, RP102, U4A, U4b
Predicted to enable U6 snRNA binding activity. Predicted to be involved in formation of quadruple SL/U4/U5/U6 snRNP and spliceosomal tri-snRNP complex assembly. Predicted to be part of U4 snRNP and U4/U6 x U5 tri-snRNP complex. Implicated in ReNU syndrome. [provided by Alliance of Genome Resources, Jun 2026]
Primary Disease Associations & Inheritance
Clinical highlights
Population Genetics & Constraint
Constraint data not available from gnomAD.
ClinVar Variant Classifications
0 submitted variants in ClinVar
Mechanism of Pathogenicity
Splicing / LOFvariant-dependentNon-coding U4 spliceosomal snRNA (not a protein — gene-level protein-mechanism predictors do not apply). De novo variants in the T-loop/Stem III critical region cause ReNU syndrome (autosomal dominant) by disrupting U4/U6 structure and 5' splice-site selection — an aberrant-splicing effect, not haploinsufficiency. Recently described biallelic variants outside the critical region cause a clinically distinct recessive disorder associated with reduced RNU4-2 expression (loss of function).
References: PMID 40297424, PMID 41951959
Expert-curated annotation. Non-coding RNA gene — protein-based mechanism predictors (Badonyi & Marsh) do not apply.
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
External Resources
Links to major genomics databases and tools